Clearstead Advisors’s Pulse Biosciences PLSE Stock Holding History

Clearstead Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28	Buy	+1	New	+$24	﹤0.01%	3559

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AWA

Argo Wealth Advisory Mclean, Virginia $181M AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Clearstead Advisors's PLSE Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 1 share worth $28. The stake represents ﹤0.01% of the portfolio and ranks #3559 among its holdings.

36 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Clearstead Advisors held 1 share of Pulse Biosciences worth $28 as of Q2 2026.
Pulse Biosciences was a new Clearstead Advisors position in Q2 2026.
Pulse Biosciences made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3559 holding.
36 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.